Urinary Epidermal Growth Factor as a Marker of Disease Progression in Children With Nephrotic Syndrome

Debbie S. Gipson, Howard Trachtman, Anne Waldo, Keisha L. Gibson, Sean Eddy, Katherine M. Dell, Tarak Srivastava, Kevin V. Lemley, Larry A. Greenbaum, Sangeeta Hingorani, Kevin E. Meyers, Frederick J. Kaskel, Kimberly J. Reidy, Christine B. Sethna, Cheryl L. Tran, Chia shi Wang, Katherine R. Tuttle, Gia Oh, Alicia M. Neu, Elizabeth BrownJen Jar Lin, Jennifer Lai Yee, Therese M. Roth, Jonathan P. Troost, Brenda W. Gillespie, Matthew G. Sampson, Matthias Kretzler, Wenjun Ju

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Introduction: Childhood-onset nephrotic syndrome has a variable clinical course. Improved predictive markers of long-term outcomes in children with nephrotic syndrome are needed. This study tests the association between baseline urinary epidermal growth factor (uEGF) excretion and longitudinal kidney function in children with nephrotic syndrome. Methods: The study evaluated 191 participants younger than 18 years enrolled in the Nephrotic Syndrome Study Network, including 118 with their first clinically indicated kidney biopsy (68 minimal change disease; 50 focal segmental glomerulosclerosis) and 73 with incident nephrotic syndrome without a biopsy. uEGF was measured at baseline for all participants and normalized by the urine creatinine (Cr) concentration. Renal epidermal growth factor (EGF) mRNA was measured in the tubular compartment microdissected from kidney biopsy cores from a subset of patients. Linear mixed models were used to test if baseline uEGF/Cr and EGF mRNA expression were associated with change in estimated glomerular filtration rate (eGFR) over time. Results: Higher uEGF/Cr at baseline was associated with slower eGFR decline during follow-up (median follow-up = 30 months). Halving of uEGF/Cr was associated with a decrease in eGFR slope of 2.0 ml/min per 1.73 m2 per year (P < 0.001) adjusted for age, race, diagnosis, baseline eGFR and proteinuria, and APOL1 genotype. In the biopsied subgroup, uEGF/Cr was correlated with EGF mRNA expression (r = 0.74; P < 0.001), but uEGF/Cr was retained over mRNA expression as the stronger predictor of eGFR slope after multivariable adjustment (decrease in eGFR slope of 1.7 ml/min per 1.73 m2 per year per log2 decrease in uEGF/Cr; P < 0.001). Conclusion: uEGF/Cr may be a useful noninvasive biomarker that can assist in predicting the long-term course of kidney function in children with incident nephrotic syndrome.

Original languageEnglish (US)
Pages (from-to)414-425
Number of pages12
JournalKidney International Reports
Volume5
Issue number4
DOIs
StatePublished - Apr 2020

Keywords

  • disease progression
  • epidermal growth factor
  • focal segmental glomerulosclerosis
  • nephrotic syndrome
  • pediatrics

ASJC Scopus subject areas

  • Ophthalmology
  • Nephrology

Fingerprint Dive into the research topics of 'Urinary Epidermal Growth Factor as a Marker of Disease Progression in Children With Nephrotic Syndrome'. Together they form a unique fingerprint.

  • Cite this

    Gipson, D. S., Trachtman, H., Waldo, A., Gibson, K. L., Eddy, S., Dell, K. M., Srivastava, T., Lemley, K. V., Greenbaum, L. A., Hingorani, S., Meyers, K. E., Kaskel, F. J., Reidy, K. J., Sethna, C. B., Tran, C. L., Wang, C. S., Tuttle, K. R., Oh, G., Neu, A. M., ... Ju, W. (2020). Urinary Epidermal Growth Factor as a Marker of Disease Progression in Children With Nephrotic Syndrome. Kidney International Reports, 5(4), 414-425. https://doi.org/10.1016/j.ekir.2019.11.018